Profile
Daniel Richner is currently the Chairman & Chief Executive Officer at M+R Spedag Group AG since 2006.
Prior to this, he worked as an Investment Advisor at HBM Partners AG from 2004 to 2006.
He also held positions as a Director at Pevion Biotech AG, and as a Principal at HBM Healthcare Investments AG, NanoDimension AG, and Cantrade Privatbank AG.
Dr. Richner received his undergraduate, graduate, and doctorate degrees from the University of Basel.
Daniel Richner active positions
| Companies | Position | Start |
|---|---|---|
M+R Spedag Group AG
M+R Spedag Group AG Air Freight/CouriersTransportation Provides transportation and logistics services | Chief Executive Officer | 01/01/2006 |
Former positions of Daniel Richner
| Companies | Position | End |
|---|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Private Equity Investor | 08/02/2006 |
NanoDimension AG | Corporate Officer/Principal | - |
| HBM HEALTHCARE INVESTMENTS AG | Corporate Officer/Principal | - |
Cantrade Privatbank AG
Cantrade Privatbank AG Regional BanksFinance Operates as a private bank | Corporate Officer/Principal | - |
Pevion Biotech AG
Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Develops efficient and safe vaccines based on proprietary technology | Director/Board Member | - |
Training of Daniel Richner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Finance |
HBM Healthcare Investments AG
HBM Healthcare Investments AG Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoDimension AG | |
M+R Spedag Group AG
M+R Spedag Group AG Air Freight/CouriersTransportation Provides transportation and logistics services | Transportation |
Pevion Biotech AG
Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Develops efficient and safe vaccines based on proprietary technology | Health Technology |
Cantrade Privatbank AG
Cantrade Privatbank AG Regional BanksFinance Operates as a private bank | Finance |
- Stock Market
- Insiders
- Daniel Richner
















